Malaria

The WorldWide Antimalarial Resistance Network (WWARN) is a collaborative platform generating innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines.

WWARN Tools and resources

The WWARN Toolkit guides researchers on how to collect reliable and comprehensive evidence needed by the public health community to identify and contain antimalarial drug resistance. 

The WWARN toolkit

The WorldWide Antimalarial Resistance Network (WWARN)(link is external) – part of IDDO - is a collaborative research network that is assessing antimalarial drug efficacy by providing policy makers with the evidence needed to plan effective strategies to contain resistance and ensure the most effective use of current and new drugs in the fight to eradicate malaria. A small increase in malaria drug efficacy could have a major impact by stopping millions of cases of recurrent malaria each year.

What does WWARN do?

How does it work?

  • We provide the malaria community with a reliable and standardised data collection platform to facilitate data sharing, pooled data analyses(link is external), and application of these findings to provide evidence for policy makers and drug developers to optimise the therapeutic life of existing and new antimalarial drugs
  • We collaborate with laboratories(link is external) across the world to provide support and advice to improve the analysis of antimalarial drug regimens during clinical trials, and in turn, enhancing the overall quality of the research data captured

WWARN's interactive mapping tools monitor and track the emergence and spread of antimalarial resistance across time and geographic location

WWARN facilitates a number of collaborative groups to undertake pooled analyses of data to answer specific research questions about malaria drug resistance.